Viewing Study NCT03884192


Ignite Creation Date: 2025-12-24 @ 3:37 PM
Ignite Modification Date: 2025-12-27 @ 1:45 AM
Study NCT ID: NCT03884192
Status: UNKNOWN
Last Update Posted: 2019-03-21
First Post: 2019-01-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Consolidation Sintilimab After Concurrent Chemoradiation in Patients With Unresectable Stage III NSCLC
Sponsor: Shandong Cancer Hospital and Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module